Fibrinogen replacement therapy for congenital fibrinogen deficiency

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 9, 2011, Pages 1687-1704

  Bornikova, L ^a   Peyvandi, F ^b   Allen, G ^c   Bernstein, J ^d   Manco Johnson, M J ^a  

^a Mountain States Regional Hemophilia and Thrombosis Center   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c BROWN UNIVERSITY   (United States)

^d Children's Center for Cancer and Blood Diseases of Las Vegas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN 40; ENOXAPARIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FIBRORAAS; FRESH FROZEN PLASMA; HAEMOCOMPLETTAN P; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NIFEDIPINE; ORAL CONTRACEPTIVE AGENT; PENTOXIFYLLINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIASTAP; TICLOPIDINE; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AFIBRINOGENEMIA; ANTIBODY PRODUCTION; BLEEDING; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CRYOPRECIPITATE; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DYSFIBRINOGENEMIA; ECCHYMOSIS; ERYTHROCYTE CONCENTRATE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; HEMARTHROSIS; HEMATOMA; HUMAN; HYPOCALCEMIA; HYPOFIBRINOGENEMIA; INFANT; INJECTION SITE HEMATOMA; INTRAMUSCULAR HEMATOMA; ISCHEMIC THROMBOSIS; LUNG EMBOLISM; LUNG INFARCTION; MALE; MENORRHAGIA; OCCLUSIVE CEREBROVASCULAR DISEASE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; SUBCORTICAL HEMORRHAGE; SUBDURAL HEMATOMA; THALAMUS HEMORRHAGE; THROMBOSIS; THROMBUS; TREATMENT DURATION;

ADOLESCENT; ADULT; AFIBRINOGENEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRINOGEN; HEMORRHAGE; HEMOSTASIS, SURGICAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOSIS; YOUNG ADULT;

EID: 80052410751     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04424.x     Document Type: Review

References (50)

1. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 11-30.
2. Acharya SS, DiMichele DM. Rare inherited disorders of fibrinogen. Haemophilia 2007; 14: 1151-8.
3. de Moerloose P, Neerman-Arbuz M. Congenital fibrinogen disorders. Semin Thromb Hemost 2009; 35: 356-66.
4. Manco-Johnson MJ, DiMichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G; Pier Mannucci for the Fibrinogen Concentrate Study Group. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost 2009; 7: 2064-9.
5. FDA Blood Products Advisory Committee meeting for RiaStap (9 January 2009). Accessed 23 March 2009.
6. Toledano A, Lachassinne E, Roumegoux C, Laurian Y, Benabadji Z, Chiadmi F, Cisternino S, Schlatter J, Fontan JE. Treatment of congenital afibrinogenemia in a premature neonate. Ann Pharmacother 2008; 42: 1145-6.
7. Parameswaran R, Dickinson JP, de Lord S, Keeling DM, Colvin BT. Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy. Haemophilia 2000; 6: 705-8.
8. Klarmann D, Martinez-Saguer I, Stoll H, Nachtrodt G, Class D, Ivaskevicius V, Oldenburg J, Kreuz W. Cranial epidural bleeding in a child with congenital afbrinogenaemia, management and long-term prophylaxis with a fibrinogen concentrate. J Thromb Haemost 2005; 3 (Suppl. 1): Abstract PO261.
9. Matsumoto T, Wada H, Tamaru S, Sugimoto Y, Fujieda A, Yamamura K, Kobayashi T, Kaneko T, Yamaguchi M, Nobori T, Katayama N. Central venous catheter-related thrombosis after replacement therapy for intracranial bleeding in a patient with afibrinogenaemia. Haemophilia 2008; 14: 153-6.
10. Henselmans JM, Meijer K, Haaxma R, Hew J, van der Meer J. Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options. Stroke 1999; 30: 2479-82.
11. Vakalopoulou S, Rizopoulou D, Zafiriadou E, Perifanis V, Tziomalos K, Lefkou E, Hill M, Dolan G, Garipidou V. Management of acute bleeding in a patient with congenital afibrinogenaemia. Haemophilia 2006; 12: 676-8.
12. De Vries A, Rosenberg T, Kochwa S, Boss JH. Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia. Am J Med 1961; 30: 486-94.
13. Patiroglu T, Karakukcu M. Middle cerebral arterial thrombosis in a patient with hypofibrinogenemia, 5 days after rFVIIa and FFP infusion. Clin Appl Thromb Hemost 2006; 12: 111-13.
14. MacKinnon HH, Fekete JF. Congenital afibrinogenemia. Vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication. CMAJ 1971; 104: 597-9.
15. De Mattia D, Regina G, Giordano P, Del Vecchio GC, Altomare M, Schettini F. Association of congenital afibrinogenemia and K-dependent protein C deficiency - a case report. Angiology 1993; 44: 745-9.
16. Korte W, Feldges A. Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution. Clin Invest 1994; 72: 396-8.
17. Oruc N, Tokat Y, Killi R, Tombuloglu M, Ilter T. Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication. Dig Dis Sci 2006; 51: 378-80.
18. Matsushita I, Uchida S, Yamaguchi A, Tanaka Y, Ogawa S, Kato K, Tsukimori K, Wake N. Interstitial pregnancy in a woman with congenital afibrinogenemia. J Obstet Gynaecol Res 2008; 34: 914-18.
19. Grech H, Majumdar G, Lawrie AS, Savidge GF. Pregnancy in congenital afibrinogenaemia: report of a successful case and review of the literature. Br J Haematol 1991; 78: 571-2.
20. Takahashi H, Wada K, Shibata A. Planned pregnancy and delivery in a patient with congenital afibrinogenaemia and heterozygous protein C deficiency. Blood Coagul Fibrinolysis 1995; 6: 141-2.
21. Kobayashi T, Asahina T, Maehara K, Itoh M, Kanayama N, Terao T. Congenital afibrinogenemia with successful delivery. Gynecol Obstet Invest 1996; 42: 66-9.
22. Roqué H, Stephenson C, Lee MJ, Funai EF, Popiolek D, Kim E, Hart D. Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies. Am J Hematol 2004; 76: 267-70.
23. Trehan AK, Fergusson IL. Congenital afibrinogenaemia and successful pregnancy outcome. Case report. Br J Obstet Gynaecol 1991; 98: 722-4.
24. Inamoto Y, Terao T. First report of case of congenital afibrinogenemia with successful delivery. Am J Obstet Gynecol 1985; 153: 803-4.
25. Kobayashi T, Kanayama N, Tokunaga N, Asahina T, Terao T. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol 2000; 109: 364-6.
26. Miesbach W, Galanakis D, Scharrer I. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy. Blood Coagul Fibrinolysis 2009; 20: 366-70.
27. Yamanaka Y, Takeuchi K, Sugimoto M, Sato A, Nakago S, Maruo T. Dysfibrinogenemia during pregnancy treated successfully with fibrinogen. Acta Obstet Gynecol Scand 2003; 82: 972-3.
28. Aygören-Pürsün E, Martinez Saguer I, Rusicke E, Louwen F, Geka F, Ivaskevicius V, Oldenburg J, Klingebiel T, Kreuz W. Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions. Am J Hematol 2007; 82: 317-20.
29. Pati S, Kombogiorgas D, Anwar A, Price RF. Spontaneous extra-axial intracranial hemorrhage followed by thrombosis in congenital afibrinogenemia: perioperative management of this rare combination. Surg Neurol 2009; 71: 689-92, discussion 692.
30. Haberer JP, Obstler C, Samama CM, Darnige L, Szwebel TA, Meyer A, Horellou MH. Postoperative deep venous thrombosis in a woman with congenital afibrinogenaemia treated with fibrinogen concentrates. Eur J Anaesthesiol 2008; 25: 519-21.
31. Dupuy E, Soria C, Molho P, Zini JM, Rosenstingl S, Laurian C, Bruneval P, Tobelem G. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res 2001; 102: 211-19.
32. Takasugi Y, Shiokawa Y, Kajikawa R, Oh J, Yamamoto Y, Sakata I, Koga Y. Mesenteric venous thrombosis in a patient with congenital afibrinogenemia and diffuse peritonitis. Ann Hematol 2005; 84: 129-30.
33. Cronin C, Fitzpatrick D, Temperley I. Multiple pulmonary emboli in a patient with afibrinogenaemia. Acta Haematol 1988; 79: 53-4.
34. Hattersley PG, Dimick ML. Cryoprecipitates in treatment of congenital fibrinogen deficiency. Case report. Transfusion 1969; 9: 261-4.
35. Shima M, Tanaka I, Sawamoto Y, Kanehiro H, Matsuo N, Nishimura A, Giddings JC, Yoshioka A. Successful treatment of two brothers with congenital afibrinogenemia for splenic rupture using heat- and solvent detergent-treated fibrinogen concentrates. J Pediatr Hematol Oncol 1997; 19: 462-5.
36. Lal AB, Maruthavanan R, Scott NB. Aortic valve repair in a patient with congenital afibrinogenemia. Anesth Analg 2005; 101: 1628-30.
37. Franz RC. Fibrinogen Pretoria - a clinical and biochemical study of a Pretoria family with fibrinogen dysfunction resulting from a gamma chain defect. S Afr Med J 2002; 92: 968-70.
38. Bolton-Maggs PHB, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, Collins PW, Kitchen S, Dolan G, Mumford AD. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organization. Haemophilia 2004; 10: 593-628.
39. Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2008; 14: 671-84.
40. Menart C, Sprunck N, Duhaut P, Pinede L, Demolombe-Rague S, Negrier C. Recurrent spontaneous intracerebral hematoma in a patient with afibrinogenemia. Thromb Haemost 1998; 79: 241-2.
41. Garcia-Monco JC, Fernandez Canton G, Gomez Beldarrain M. Bilateral vertebral artery dissection in a patient with afibrinogenemia. Stroke 1996; 27: 2325-7.
42. Rodriguez RC, Buchanan GR, Clanton MS. Prophylactic cryoprecipitate in congenital afibrinogenemia. Clin Pediatr (Phila) 1988; 27: 543-5.
43. Ehmann WC, al-Mondhiry H. Congenital afibrinogenemia and splenic rupture. Am J Med 1994; 96: 92-4.
44. Angles-Cano E, Mathonnet F, Dreyfus M, Claeyssens S, de Mazancourt P. A case of afibrinogenemia associated with A-alpha chain gene compound heterozygosity (HUMFIBRA c.[4110delA]+[3200 + 1G>T]). Blood Coagul Fibrinolysis 2007; 18: 73-5.
45. Mehta S, Mehta SR, Malhotra H, Sharma UB, Varma AR. Congenital afibrinogenaemia. J Assoc Physicians India 1989; 37: 668-9.
46. Thompson HW, Touris S, Giambartolomei S, Nuss R. Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors. J Clin Apher 1998; 13: 143-5.
47. Datta Kanjilal S, Bagchi S. Acute osteomyelitis in congenital hypofibrinogenemia. Indian J Pediatr 2006; 73: 529-30.
48. Goodwin TM. Congenital hypofibrinogenemia in pregnancy. Obstet Gynecol Surv 1989; 44: 157-61.
49. McLeod BC, McKenna R, Sassetti RJ. Treatment of von Willebrand's disease and hypofibrinogenemia with single donor cryoprecipitate from plasma exchange donation. Am J Hematol 1989; 32: 112-16.
50. Kitchens CS, Cruz AC, Kant JA. A unique 7p/12q chromosomal abnormality associated with recurrent abortion and hypofibrinogenemia. Blood 1987; 70: 921-5.